Denitist

Acquiring cash-generative aesthetic, dermatology and specialist medical businesses through disciplined underwriting and structured consolidation.

Governance-led. Transaction-focused.
Built for institutional ownership.

European Healthcare Acquisition Platform

About us

Linka Group is a European healthcare acquisition platform focused on acquiring and consolidating established aesthetic, dermatology and specialist medical businesses.

Many specialist healthcare businesses operate with fragmented ownership, limited financial infrastructure and succession challenges.

We focus exclusively on profitable, well-run clinics and apply structured financial discipline, governance, and reporting from acquisition.

The platform is built to institutional standards from inception, prioritising underwriting quality, capital preservation, and controlled scaling over acquisition volume.

Every transaction is structured with clear downside protection.

Founder & Managing Director

Leads platform strategy, acquisitions and capital deployment across Linka Group.

Responsible for deal origination, transaction structuring and negotiation, from initial approach through execution.

Focused on disciplined pricing, downside protection and value creation through scaled consolidation.

Dr. Pierre A. Morgon
Chairman
Karolis Linkevicius

International life sciences executive and board chairman with 40+ years across global pharmaceutical, vaccine and healthcare organisations.

Former senior executive and Executive Committee member at Sanofi Pasteur, with senior leadership experience at Aventis Pasteur and Bristol-Myers Squibb, among others. His career includes operating within global organisations such as Aventis (€17.8bn in annual sales; ~75,000 employees) and Bristol-Myers Squibb ($19.4bn in annual sales; ~43,000 employees).

Brings extensive experience in global operations, cross-border transactions, capital markets and institutional governance.

Provides Linka Group with board-level discipline, transaction oversight, capital markets credibility and strategic leadership.

Karen Sands

CFO with 25+ years of senior finance, M&A and private equity experience, with mandates from leading sponsors including Bain Capital, Montagu Private Equity, Triton Partners and Inflexion.

30+ acquisitions and M&A transactions across buy-and-build, integrations, carve-outs and refinancings, with experience across businesses generating £1bn+ in revenue and £1bn+ of acquired assets.

Former Group CFO of a £767m-revenue international group, where she restructured £45m of senior debt and led a 50+ person finance function.

ACA and CTA qualified, with a PhD in IFRS accounting. Karen brings financial oversight, transaction execution and capital-structure expertise to Linka Group’s acquisition platform.

Leadership

Financial Lead
Dr. Toni Phillips
Clinical & Operating Advisor

Senior aesthetic medicine operator with 20 years’ experience across UK aesthetic clinic platforms and medically-led multi-site businesses.

Founding clinical leader at Renew Medica, which transitioned into Destination Skin and was subsequently acquired by sk. She has held senior clinical roles with Harrods (The Wellness Clinic), KX Private Members Health Club and sk.

Provides clinical diligence, practitioner assessment and operational validation across Linka Group’s acquisition platform.

Execution Model

Disciplined and centralised:

  • Centralised deal screening and underwriting

  • Standardised acquisition structures

  • Independent challenge on valuation and risk

  • Immediate financial control post-acquisition

  • Phased integration (financial first, operational second)

  • Disciplined capital allocation across the portfolio

We engage selectively with clinic owners, advisors, and financing partners aligned with long-term value creation.

Contact Us

Acquisition Opportunities, Advisory Relationships, and Financing Discussions

Get in Touch

Email: founder@linkagroup.eu

Phone: 020 3355 8075